Viewing Study NCT02614469


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2026-01-03 @ 12:04 PM
Study NCT ID: NCT02614469
Status: COMPLETED
Last Update Posted: 2017-03-29
First Post: 2015-11-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Food-Drug Interaction Study of Serum Urate After Oral Inosine
Sponsor: Michael Alan Schwarzschild
Organization:

Study Overview

Official Title: A Phase 1, Open-label, Randomized, Two-period, Two-treatment, Crossover Study to Evaluate the Effects of Food on the Pharmacokinetics of Urate After a Single Dose of Inosine in Healthy Male Subjects
Status: COMPLETED
Status Verified Date: 2017-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to assess the effects of food on the amount of urate in the body after a single oral dose of inosine.
Detailed Description: Eighteen (18) eligible healthy male subjects will be randomly assigned to two groups with 9 subjects per group to receive a single oral dose of 1000 mg inosine with or without food on day 1 after an overnight fast. Subjects who receive inosine with food on day 1 will receive a second dose of inosine without food on day 8 after an overnight fast. Subjects who receive inosine without food on day 1 after an overnight fast will receive a second dose of inosine with food on day 8 after an overnight fast.

Subjects will be admitted to the clinic before dinner on days 0 and 7, the days before dosing, and will stay in the clinic for 48-h post-dose. During the clinic stay, blood samples will be taken for urate measurements.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: